Parametric Portfolio Associates’s Pulse Biosciences PLSE Stock Holding History
Bought
Maintained
Sold
Other funds holding PLSE
Parametric Portfolio Associates's PLSE Position: Q1 2022 in Review
Parametric Portfolio Associates reduced its Pulse Biosciences (PLSE) stake by 35% in Q1 2022, selling an estimated $112K and leaving 25,714 shares worth $125K. The position accounts for ﹤0.01% of the portfolio, ranked #3526.
Parametric Portfolio Associates first reported a position in PLSE in Q3 2019 and has held it in 11 quarters since. The position peaked at $1.11M in Q1 2021. 55 funds tracked by Wall St. Rank hold PLSE as of Q1 2022.
- Parametric Portfolio Associates held 25,714 shares of Pulse Biosciences worth $125K as of Q1 2022.
- Parametric Portfolio Associates sold 13,704 Pulse Biosciences shares in Q1 2022, an estimated $112K.
- Pulse Biosciences made up ﹤0.01% of Parametric Portfolio Associates's portfolio in Q1 2022, its #3526 holding.
- Parametric Portfolio Associates first reported a position in Pulse Biosciences in Q3 2019 and has held it in 11 quarters since.
- Parametric Portfolio Associates's Pulse Biosciences position peaked at $1.11M in Q1 2021.
- 55 funds tracked by Wall St. Rank held Pulse Biosciences as of Q1 2022.
Based on Parametric Portfolio Associates's 13F filing for Q1 2022, filed 16 May 2022.